Support & Resources

+1

Fish Gelatin Powder

Gelatin from fish skin that can be added to blocking buffers to minimize non-specific antibody binding in immuno-detection procedures such as western blotting and cell staining.

Product Attributes

Storage Conditions

Store at room temperature

Note: Due to operating restrictions related to our COVID-19 response, primary antibody conjugates of R-PE, APC, PerCP, HRP, or AP are temporarily unavailable. All other antibody options are still available. We apologize for the inconvenience. Please see our easy-to-use Mix-n-Stain™ Antibody Labeling Kits for labeling antibodies with R-PE, APC, tandem dyes, and enzymes.
Size
Catalog #
price
Qty
2 x 50 g
Clear selection
Add to wishlist
ADD TO CART
(Please select quantity above )

Wishlist updated! View wishlist

Shipping, Handling & Tax (CA only) not included in price. Learn more

Tax is assessed in the state of California. All fees will be calculated during checkout based on your shipping information and are subject to change.

SPECIAL - Order 5 or more and receive 10% off.

Request a Bulk Quote

Protocols
SDS

Product Description

Fish Gelatin Powder is purified from cold water fish skin. It can be used to make blocking buffers to minimize non-specific antibody binding in immunodetection procedures such as western blotting, immunofluorescence, and IHC.

  • Gelatin purified from cold water fish skin
  • Blocking agent for immuno-assays (ie, western blot, IHC, IF)
  • Minimizes non-specific antibody binding
  • Contains no IgG or serum proteins, won’t cross-react with mammalian antibodies
  • 2 x 50g of solid gelatin
  • Store solid at room temperature

Fish gelatin can be used to block non-specific binding sites on positively charged nylon or PVDF membranes or used for blocking and dilution of antibodies during immunostaining procedures. Unlike BSA or milk, fish gelatin does not contain IgG or serum proteins that could cross-react with mammalian antibodies.

References

1. Oncotarget (2017) Sep 28;8(49):86657-86670 doi:10.18632/oncotarget.21364
2. Heliyon (2018) Nov 16;4(11):e00917 doi:10.1016/j.heliyon.2018.e00917
3. Exp Eye Res (2019) Mar;180:122-128 doi:10.1016/j.exer.2018.12.016
4. Environ Mol Mutagen (2020) Feb;61(2):235-245 doi:10.1002/em.22331

 

You may also like…